Abstract

This is a Photo Essay and does not have an abstract.

Highlights

  • A 64-year-old man with myasthenia gravis (MG) presented with blurry vision in his left eye (OS)

  • There was a decrease in the dosage and eventual cessation of mycophenolate mofetil (MMF) with initiation of intravenous immunoglobulins. His lymphocytes improved to 9.8%

  • On valganciclovir discontinuation in week 10, the patient had a visual acuity of 20/25 OS with no inflammation and improvements in retinal hemorrhages and lesions

Read more

Summary

Photo Essay

A 64-year-old man with myasthenia gravis (MG) presented with blurry vision in his left eye (OS) His visual acuity was 20/20 in the right eye and 20/50 OS. He had 1+ vitritis and vaso-occlusive appearance of the retina with sclerotic vessels and hemorrhages in the inferonasal quadrant OS (Figure 1), consistent with features of cytomegalovirus (CMV) retinitis. He was immunocompromised secondary to mycophenolate mofetil (MMF) administered for MG, with 0.6% lymphocytes (normal: 26.0–46.0%), a lymphocyte count of 0.1×103 cells/μL, and a leukocyte count of 11.3×103 cells/μL. The human immunodeficiency virus (HIV) test result was negative, and no further workup for immunosuppression, including cancer, was conducted

Access this article online
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call